Ishara Biotech Fund LP — Form D/A
Ishara Biotech Fund LP of LOS ANGELES, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2026-01-20. $8.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-01-20
- Form: D/A
- Accession: 0001104659-26-005001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.1
- Amount sold: $8.5M
- Investors: 11
- Date of first sale: 2025-01-02
- Security types: fund interests
- SEC file number: 021-535668
Issuer
- Name: Ishara Biotech Fund LP
- CIK: 0002052609
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 8929 EXPOSITION BOULEVARD, LOS ANGELES, CA, 90034
- Phone: (818) 983-4448
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A Ishara Investments LP | Executive Officer | Los Angeles, CA |
| N/A Ishara Partners GP, LLC | Executive Officer | Los Angeles, CA |
| Shaun Ravi Mehra | Executive Officer | Los Angeles, CA |
Other filings by this issuer (1)
More